DV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that DoubleVerify Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of DoubleVerify Holdings, Inc. (NYSE: DV) common... Read more.
Onc.AI to Present Breakthrough Deep Learning Radiomic Biomarker Results at 2025 ASCO Annual Meeting
CHICAGO–(BUSINESS WIRE)–Onc.AI, a digital health company developing AI-powered oncology clinical management solutions, today announced that new validation... Read more.
Zenlayer Named Equinix Global Partner of the Year
The leading edge compute and networking provider recognized for accelerating digital transformation and AI innovation across 50+ countries. LOS ANGELES–(BUSINESS... Read more.
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer after EGFR TKI Therapy in Global Study
Consistent Results Noted between Single Region HARMONi-A and Multiregional HARMONi Studies; Favorable Trends in Sub-Populations from North America and China for... Read more.
Wolters Kluwer Launches Lippincott Nursing Advisory Board to Elevate Clinical Excellence in India
Launched at ANEICON 2025, the initiative unites India’s top nursing minds to shape the future of care through collaboration, innovation, and evidence-based practice... Read more.
MangoBoost and AIC Sign MoU to Explore Collaboration on DPU-Based Server and Storage Solutions
BELLEVUE, Wash.–(BUSINESS WIRE)–#AI–MangoBoost, a provider of cutting-edge system solutions for maximizing compute efficiency and scalability,... Read more.
Dakota Johnson Named Global Brand Ambassador for Roberto Coin: Award-Winning Actress and Advocate Stars in New Jewelry Campaign
NEW YORK–(BUSINESS WIRE)–Roberto Coin, the renowned Italian maison known for its sophisticated design, romance, and impeccable craftsmanship, proudly... Read more.
Tamboran announces successful closing of First Tranche of PIPE
Highlights Tamboran Resource Corporation has closed the first tranche of its previously announced Private Investment Public Equity (PIPE) of Common Stock (First... Read more.
Iksuda Therapeutics announces first patient successfully dosed in phase 1 trial evaluating IKS03 in advanced B cell non-Hodgkin lymphomas
First-in-human trial is designed to determine recommended dose of IKS03, a CD19-directed antibody drug conjugate, for the subsequent dose-expansion IKS03 is Iksuda’s... Read more.
Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis
– Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatment –... Read more.